Medicare Enrolled

Dr. Tesa Linstad, NURSE PRACTITIONER

Nurse Practitioner - Family · Yakima, WA
Low-engagement
1806 W LINCOLN AVE, Yakima, WA 98902
5094524520
In practice since 2019 (7 years)
NPI: 1952868713 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Linstad from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Linstad? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Linstad

Dr. Tesa Linstad is a nurse practitioner - family in Yakima, WA, with 7 years of NPI registration.

Between the years covered by Open Payments, Dr. Linstad received a total of $6,120 from 37 pharmaceutical and/or device companies across 244 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in nurse practitioner - family. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Linstad is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 7 years in practice $6,120 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$6,120
Total received (2021-2024)
Avg $1,530/year across 4 years
Top 2% in WA for nurse practitioner - family
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
244
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,120 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,770
2023
$2,258
2022
$818
2021
$274

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$471
Novartis Pharmaceuticals Corporation
$291
ARGENX US, INC.
$219
Neurelis, Inc.
$176
Teva Pharmaceuticals USA, Inc.
$172
UCB, Inc.
$155
PFIZER INC.
$155
AstraZeneca Pharmaceuticals LP
$144
Alexion Pharmaceuticals, Inc.
$132
E.R. Squibb & Sons, L.L.C.
$126
Lilly USA, LLC
$89
Eisai Inc.
$86
BANNER LIFE SCIENCES, LLC
$76
Acorda Therapeutics, Inc
$75
EMD Serono, Inc.
$62
SK Life Science, Inc.
$55
Celgene Corporation
$53
Otsuka America Pharmaceutical, Inc.
$47
Genentech USA, Inc.
$46
Alnylam Pharmaceuticals Inc.
$39
JAZZ PHARMACEUTICALS INC.
$25
Biogen, Inc.
$24
TG Therapeutics, Inc.
$22
Cala Health, Inc.
$18
Kyowa Kirin, Inc.
$15
Top 3 companies account for 35.4% of 2024 payments
All-time payments by company (2021-2024) ›
ABBVIE INC.
$1,283
AstraZeneca Pharmaceuticals LP
$481
ARGENX US, INC.
$441
Neurelis, Inc.
$416
Novartis Pharmaceuticals Corporation
$338
Teva Pharmaceuticals USA, Inc.
$335
Neurocrine Biosciences, Inc.
$297
Lilly USA, LLC
$201
PFIZER INC.
$197
UCB, Inc.
$195
Sumitomo Pharma America, Inc.
$161
Biogen, Inc.
$152
Acorda Therapeutics, Inc
$151
Neuronetics, Inc.
$149
Sunovion Pharmaceuticals Inc.
$146
BANNER LIFE SCIENCES, LLC
$137
Alexion Pharmaceuticals, Inc.
$132
E.R. Squibb & Sons, L.L.C.
$126
SK Life Science, Inc.
$104
Eisai Inc.
$101
Celgene Corporation
$92
EMD Serono, Inc.
$62
Janssen Pharmaceuticals, Inc
$57
Otsuka America Pharmaceutical, Inc.
$47
Genentech USA, Inc.
$46
Alnylam Pharmaceuticals Inc.
$39
Amneal Pharmaceuticals LLC
$37
Biohaven Pharmaceuticals, Inc.
$26
JAZZ PHARMACEUTICALS INC.
$25
TG Therapeutics, Inc.
$22
Adamas Pharmaceuticals, Inc.
$20
Amylyx Pharmaceuticals, Inc.
$19
Lundbeck LLC
$18
Cala Health, Inc.
$18
GENZYME CORPORATION
$17
Novo Nordisk Inc
$17
Kyowa Kirin, Inc.
$15
Top 3 companies account for 36.0% of all-time payments
Associated products mentioned in payments ›
AMVUTTRA · AMYVID · APTIOM · AUSTEDO · Austedo XR · BAFIERTAM · BRIUMVI · Briviact · CALA KIQ · ELIQUIS · EMGALITY · EPIDIOLEX · FARXIGA · GOCOVRI · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · Leqembi · NEUROSTAR TMS THERAPY SYSTEM · NURTEC ODT · Nayzilam · Nourianz · ONGENTYS · ONPATTRO · Ocrevus · Ocrevus Zunovo · Ongentys · PAXLOVID · QULIPTA · RELYVRIO · REXULTI · RYTARY · Rystiggo · SPRAVATO · TYSABRI · UBRELVY · ULTOMIRIS · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Wegovy · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for nurse practitioner - family in WA.

Looking for a nurse practitioner - family in Yakima?
Compare family nurse practitioners in the Yakima area by procedure volume, costs, and industry payment transparency.
Browse family nurse practitioners nearby

Geographic Context

Family nurse practitioners within 10 mi
71
Per 100K population
27.7
County median income
$68,015
Nearest hospital
YAKIMA VALLEY MEMORIAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Linstad is a nurse practitioner - family, with low-engagement industry engagement in the top 2% of WA peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Linstad receive payments from pharmaceutical companies?
Yes. Dr. Linstad received a total of $6,120 from 37 companies across 244 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Linstad) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Family Nurse Practitioners in Yakima
Browse family nurse practitioners in Yakima ranked by procedure volume and transparency data.
Highest volume
Top Family Nurse Practitioners in WA
Family nurse practitioners ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Nurse Practitioners in WA
Which WA family nurse practitioners receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
ARGENX US, INC. Payments to Doctors
See all physicians who received payments from ARGENX US, INC.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →